Advanced Compound Annotation Service

As an additional service, MetaSysX offers in-depth annotation of unknown features identified through untargeted analysis—particularly those that are statistically significant, discriminative, or potential diagnostic biomarkers. This service is exclusively available for data generated within the MetaSysX platform.

The annotation process involves targeted LC-MS/MS measurements followed by expert interpretation of the resulting fragmentation spectra. A specialist analyzes diagnostic fragment ions, fragmentation patterns, and neutral losses to identify compounds of interest—such as bioactive molecules relevant to specific biological conditions.

Successful annotation relies on expert knowledge of mass spectrometry and compound chemistry.
At MetaSysX, our team uses the internal database containing thousands of curated fragmentation spectra, in combination with external databases and AI-assisted analysis pipelines, to achieve reliable compound identification.

What is typically a time-consuming and technically demanding process becoming a insightful step toward discovery when handled by our specialists—turning your complex data into breakthroughs for research, biomarker or bioactives discovery.